Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20111
20122
20131
20141
20153
20163
20171
20181
20196
20203
20215
20222
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
RemeGen Co., Ltd.4
Peking University People's Hospital3
RenJi Hospital3
Tuen Mun Hospital3
AbbVie2
Chinese University of Hong Kong2
Peking Union Medical College Hospital2
Sun Yat-sen University2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic39
Autoimmune Diseases2
Lupus Nephritis2
Anemia, Hemolytic, Autoimmune1
Arthritis, Juvenile1
Connective Tissue Diseases1
Glomerulonephritis1
Hypertension, Pulmonary1
Infections1
Kidney Diseases1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.